neoadjuvant therapy

Resident studies outcomes of neoadjuvant therapy for UNMC breast cancer patients

Nila Jones, MD, a second-year resident in UNMC’s Department of Pathology, Microbiology and Immunology, is taking a comprehensive look at patient outcomes of neoadjuvant breast cancer therapy for UNMC patients between 2014 and 2024.

Jun 25, 2025

Nila Jones, MD, a second-year anatomic and clinical pathology resident in UNMC's Department of Pathology, Microbiology and Immunology
ErRAfSFq KqQHkyjRNwgRbDEbYe s